ArticleiScience2026
Interpretable multimodal MRI fusion in Alzheimer's disease classification using extended parallel multilink joint ICA and 3D ResNet.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Accurate identification of Alzheimer's disease (AD) stages is important for improving clinical understanding and supporting early-stage assessment. In this study, two multimodal MRI fusion strategies were developed to integrate structural MRI, resting-state functional MRI, and diffusion tensor imaging for pairwise binary classification among four groups: normal cognition (NC), subjective cognitive decline (SCD), mild cognitive impairment (MCI), and AD dementia (ADD). The extended parallel multilink joint independent component analysis (Epml-jICA) combined with a support vector machine (SVM) approach (machine learning) and the ensemble 3D ResNet model (deep learning) were evaluated on 664 participants with multimodal MRI. The results demonstrated that the optimal area under the receiver operating curve (AUROC) values for ADD vs. NC and SCD vs. NC were 95.68% and 81.25%, respectively. Furthermore, systematic interpretability analyses using SHAP, Grad-CAM, and anatomical localization of cross-modal important components were conducted, identifying model-associated imaging patterns that were consistent with prior AD-related findings and may provide insights into different disease stages.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.